Shares in Australian pharma Immuron are going nuts

Shares in pharmaceutical company Immuron Limited surged by 80% when it announced promising results in testing its anti-inflammation drug. The Australian microbiome is developing and commercialising treatments for inflammatory and infectious diseases. https://www.businessinsider.com.au/shares-in-australian-pharma-immuron-are-going-nuts-2018-3

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.